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Background: Malaria in highland areas of Kenya affects children and adults. Local clinicians include symptoms other
than fever when screening for malaria because they believe that fever alone does not capture all cases of malaria.
Methods: Individuals who presented to dispensaries in a highland Kenya site of low, unstable malaria transmission from
2007–2011 with 1 or more of 11 symptoms were tested by microscopy for malaria. Clinical malaria was defined as asexual
Plasmodium falciparum infection on peripheral blood smear in an individual with any screening symptom. Asymptomatic
P. falciparum infection was assessed in a cohort at ten time points to determine the extent to which symptomatic
episodes with parasitaemia might be attributable to baseline (asymptomatic) parasitaemia in the community.
Results: 3,420 individuals were screened for malaria, 634 < 5 years of age and 2,786≥ 5 years of age. For the diagnosis of
clinical malaria, the symptom of fever had a sensitivity and specificity of 88.9% and15.4% in children <5 years, and 55.8%
and 54.4% in children ≥5 years, respectively. Adding the symptom of headache increased sensitivity to 94. 4% in
children <5 years and 96.8% in individuals ≥5 years, but decreased specificity to 9.9% and 11.6%, respectively, and
increased the number of individuals who would be tested by 6% and 92%, respectively. No combination of symptoms
improved upon the presence fever or headache for detection of clinical malaria. In the cohort of asymptomatic
individuals, P. falciparum parasitaemia was infrequent (0.1%).
Conclusion: In areas of low, unstable malaria transmission, fever is a sensitive indicator of clinical malaria in
children <5 years, but not in older children and adults. Adding headache to fever as screening symptom increases
sensitivity of detection in individuals ≥5 years old at the cost of decreased specificity. Screening for symptoms in
addition to fever may be required to accurately capture all cases of clinical malaria in individuals ≥5 years old in
areas of low malaria transmission.
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Fever is the universal screening symptom for malaria in
research studies [1-4], but the highland areas of Kenya are
unusual in that they have historically had little malaria in-
cidence. Malaria appears to have been introduced by rail
and travel of persons from endemic populations to high-
land areas for tea planting and harvesting in the early
1900s [5,6]. Thus, families in this area have not had* Correspondence: lucianialbino@yahoo.co.uk
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unless otherwise stated.generations of exposure to malaria, as have families in
nearby areas, such as Nyanza Province [7,8]. This is sup-
ported by the relative lack of sickle cell trait and G6PD de-
ficiency in individuals in the highland areas as compared
to individuals in lowland areas [9]. Thus symptoms and
immunity in this population may differ from those in
populations with a long history of exposure (e.g. Nyanza
Province) and in populations with no exposure for decades
(e.g. the United States and Europe). In the highland sites
of Kipsamoite and Kapsisiywa, in Nandi North District,
Rift Valley Province, Kenya, where our research team has
conducted malaria research for the past decade, localal Ltd. This is an Open Access article distributed under the terms of the Creative
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toms in addition to fever to capture all cases of malaria.
Kipsamoite and Kapsisiywa experienced an atypical situ-
ation in 2007, when widespread indoor residual spraying
(IRS) with long-lasting insecticides and introduction of arte-
misinin combination therapy with artemether-lumefantrine
(Coartem©) led to a 14-month period with no clinical cases
of malaria and possible interruption of malaria transmission
[10]. After this period, asymptomatic parasitaemia has been
infrequent in these communities, providing a unique oppor-
tunity to study the sensitivity and specificity of fever and
other symptoms for P. falciparum parasitaemia, which at
this point occur almost exclusively in individuals with symp-
toms that lead them to seek evaluation and treatment at the
health dispensaries on site. Individuals with any of eleven
symptoms considered consistent with malaria by study clin-
ical officers were tested for malaria by microscopy. In the
present study, sensitivity and specificity of individual symp-
toms and combinations of symptoms for clinical malaria
were assessed, with the primary definition of clinical being
P. falciparum parasitaemia in any symptomatic individual.
Sensitivity and specificity of individual symptoms and com-
binations of symptoms for alternate definitions of clinical
malaria were also assessed, including: (1) P. falciparum para-
sitaemia with measured fever (axillary temperature ≥37.5°C),
(2) P. falciparum parasitaemia ≥ 1,000 parasites/μL with
measured fever, or (3) P. falciparum parasitaemia ≥ 4,000
parasites/μL with measured fever.
Methods
Study population and recruitment
The study was conducted in the Kenyan highland sites of
Kipsamoite (population ~4,800) and Kapsisiywa (popula-
tion ~4,000), Nandi County, from 2007 to 2011. Elevation
ranges from 1,887 m to 2,132 m at these sites. The area
has seasonal, unstable malaria transmission and a history
of past malaria epidemics and a recent possible interrup-
tion of malaria transmission from April 2007 to May 2008,
with no clinical cases of malaria identified in that period
[10]. Persons living in these areas are predominantly
Nandi, a Kalenjinsub-tribe. Written informed consent for
study participation was obtained from heads of house-
holds in the area for demographic studies and from in-
dividuals (or parents or guardians of persons <15 years
of age) for other studies. Ethical approval for the study
was obtained from the Kenya Medical Research Institute
National Ethical Review Committee and the Institutional
Review Board for Human Studies at the University of
Minnesota.
Demography and surveillance for clinical malaria and
asymptomatic parasitaemia
Demographic surveys and malaria surveillance were per-
formed in these areas. Demography of households wasdone annually. Surveillance for clinical malaria was con-
ducted at the Kenyan Ministry of Health dispensaries in
both sites, which are the only health care facilities within
the area. Free malaria diagnosis and treatment were avail-
able to all persons within the area. Individuals with symp-
toms consistent with malaria who did not have a clear
alternative diagnosis were tested for Plasmodium species
by microscopic examination of blood smears. The symp-
toms were determined by local clinical officers and in-
cluded fever, chills, headache, loss of appetite, vomiting,
jaundice, diarrhea, backache, joint pains, nausea, and se-
vere malaise. Microscopy was performed as previously de-
scribed [11] with2 independent readings and a third reading
for slides with discordant results. All persons with positive
blood smears for P. falciparum or Plasmodium malariae,
the only Plasmodium species documented in this area, were
treated with artemether-lumefantrine (Coartem©). In order
to determine the extent to which baseline asymptomatic
parasitaemia in the community might contribute to parasit-
aemia detected in symptomatic individuals, ten surveys for
asymptomatic P. falciparum parasitaemia were conducted
in a cohort of randomly selected individuals from the sites
between2007 and 2011.
Statistical analysis
Since clinical immunity to malaria differs in most popula-
tions in children <5 years of age as compared to individ-
uals ≥5 years of age, analyses were done separately for
individuals in these two age groups. Frequency of symptoms
in individuals with versus without parasitaemia was com-
pared by c2 testing. Logistic regression was conducted to
compare odds of having P. falciparum parasitaemia or
P. falciparum parasitaemia with a measured tempera-
ture ≥37.5°C with a specific symptom. Data were analysed
using Stata Version 11 (Stata Corp, College Station, Texas,
USA) and R(R Foundation, Wien, Austria).
Results
Sensitivity and specificity of specific symptoms for
clinical malaria
During the study period, only 3/3,420 smears done were
positive for P. malariae (0.09%),so only the results for in-
dividuals positive for P. falciparum were analysed. From
2007 to 2011, 3,420 individuals were screened for malaria,
and P. falciparum parasitaemia was detected in 224 indi-
viduals (6.5%), including 36/634 children <5 years (5.7%)
and 188/786 individuals ≥5 years (6.7%, P = 0.33). The me-
dian parasite density was 30,700 (IQR 10,770 - 135390), and
did not differ in children <5 years (768 [IQR 295–3202])
compared to individuals ≥5 years (19,420 [IQR 3230–
56,920], P = 0.32).
The frequency of individual symptoms for clinical mal-
aria, defined as P. falciparum parasitaemia in a person with
any of the eleven symptoms, along with the sensitivity and
Table 2 Frequency, sensitivity and specificity of
symptoms for clinical malaria (symptomatic Plasmodium









Headache 167 (89) 2055 (79) 0. 001 88. 8 20. 9
Fever 105 (56) 1185 (46) 0. 01 55. 9 54. 4
Appetite loss 69 (37) 834 (32) 0. 19 36. 7 67. 9
Chills 68 (36) 457 (18) <0. 001 36. 2 82. 4
Joint pains 57 (30) 641 (25) 0. 08 30. 3 75. 3
Vomiting 48 (26) 460 (18) 0. 01 25. 5 82. 3
Malaise 36 (19) 325 (13) 0. 01 19. 1 87. 5
Backache 35 (19) 494 (19) 0. 89 18. 6 81
Nausea 26 (14) 447 (17) 0. 23 13. 8 82. 8
Diarrhoea 6 (3) 323 (12) <0. 001 3. 2 87. 6
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children <5 years and in Table 2 for individuals ≥5 years.
Findings for clinical malaria defined as symptomatic
P. falciparum parasitaemia with measured fever (axillary
temperature ≥ 37.5°C) are summarized in Additional files
1 and 2. Negative and positive predictive values are not
shown, because the low frequency of P. falciparum para-
sitaemia in participants seen at these clinics led to high
negative predictive values (all >96%) and low positive pre-
dictive values (all <16%) for all symptoms assessed.
Symptoms with the greatest specificity lacked sensitivity
(e.g. chills in children < 5 years had a specificity 91%, but a
sensitivity of only 28%), and those with the greatest sensi-
tivity lacked specificity (e.g. fever in children <5 years had
a sensitivity of 89%, but a specificity of only 15%). Of par-
ticular interest, fever in individuals ≥ 5 years was neither
sensitive (56%) nor specific (54%).Jaundice 2 (1) 25 (1) 0. 89 1. 1 99
aTotal N for Pf pos, N = 188.
bTotal N for Pf neg, N = 2598.Odds of clinical malaria with specific symptoms
Table 3 summarizes the odds ratios for presence of each
symptom for clinical malaria in children <5 years and indi-
viduals ≥ 5 years. Individuals <5 years and ≥5 years with
P. falciparum parasitaemia were significantly more likely to
have headache, malaise, and chills than those without para-
sitaemia. Individuals ≥5 years with P. falciparum parasit-
aemia were also significantly more likely to have fever and
vomiting, and significantly less likely to have diarrhoea,
than those without parasitaemia. Findings for the outcome
of P. falciparum parasitaemia with measured fever (axillary
temperature ≥37.5°C) were very similar and are summa-
rized in Additional file 3.Table 1 Frequency, sensitivity and specificity of
symptoms for clinical malaria (symptomatic Plasmodium









Fever 32 (89) 506 (85) 0. 49 88. 9 15. 4
Appetite loss 25 (64) 323 (54) 0. 07 69. 4 46
Headache 19 (53) 191 (32) 0. 01 52. 8 68. 1
Vomiting 11 (31) 237 (40) 0. 28 30. 6 60. 4
Chills 10 (28) 56 (9) <0. 001 27. 8 90. 6
Malaise 7 (19) 53 (9) 0. 04 19. 4 91. 1
Diarrhea 5 (14) 121 (20) 0. 35 13. 9 79. 8
Nausea 3 (8) 30 (5) 0. 38 8. 3 95
Joint pains 1 (3) 12 (2) 0. 75 2. 8 98
Jaundice 0 (0) 7 (1) 0. 51 0 98. 8
Backache 0 (0) 8 (1) 0. 49 0 98. 7
Abbreviations: Pf P. falciparum, pos positive, neg negative.
aTotal N for Pf pos, N = 36.
bTotal N for Pf neg, N = 598.Sensitivity and specificity of combinations of symptoms
for P. falciparum parasitaemia
To assess whether any combination of symptoms could
improve on fever for sensitivity and specificity of detection
of clinical malaria, a three-step process was undertaken:
(1) candidate subsets of symptoms to consider were se-
lected; (2) for each candidate subset of symptoms, a logis-
tic regression model was fitted including those symptoms;
(3) the logistic regression results were used to define
rules and estimate their sensitivity and specificity. The
results of this assessment are summarized in Table 4 (for
individuals <5 years) and Table 5 (for individuals ≥ 5 years).
As documented in Tables 4 and 5, no combination of
symptoms had higher sensitivity than presence of fever or
headache for detection of clinical malaria, although thisTable 3 Odds ratios of symptoms for prediction of clinical
malaria (symptomatic Plasmodium falciparum parasitaemia)
Predictor <5 years ≥5 years
OR 95% CI P OR 95% CI P
Fever 1. 96 0. 59–6. 53 0. 27 1. 47 1. 09–1. 97 0. 01
Headache 2. 54 1. 28–5. 04 0. 01 2. 04 1. 3–3. 21 0. 002
Appetite loss 2. 14 1. 01–4. 53 0. 05 1. 21 0. 89–1. 65 0. 22
Vomiting 0. 7 0. 34–1. 46 0. 34 1. 74 1. 25–2. 43 0. 001
Chills 3. 88 1. 77–8. 49 0. 001 2. 63 1. 93–3. 51 <0. 001
Jaundice 1 - - 1. 08 0. 25–4. 60 0. 92
Diarrhoea 0. 5 0. 18–1. 46 0. 21 0. 23 0. 1–0. 52 <0. 001
Backache 1 - - 0. 95 0. 65–1. 38 0. 78
Joint pains 1. 44 0. 12–11. 39 0. 73 1. 29 0. 93–1. 78 0. 13
Nausea 1. 78 0. 52–6. 14 0. 36 0. 79 0. 52–1. 2 0. 27
Malaise 2. 58 1. 07–6. 18 0. 03 1. 67 1. 15–2. 44 0. 01
Table 4 Sensitivity and specificity of combinations of
symptoms for different clinical malaria definitions in
children <5 years of age
A. Symptomatic P. falciparum parasitaemia
Predictors Rule Sensitivity (%) Specificity (%)
Fever Fever 88. 9 15. 4
F, C, H, M, A Any of F, C, H, M, A 97. 2 5. 5
F, C, H, M Any of F, C, H, M 94. 4 8. 0
F, C, H Any of F, C, H 94. 4 8. 9
F, C F or C 88. 9 13. 4
F, H F or H 94. 4 9. 9
B. Symptomatic P. falciparum parasitaemia plus T≥ 37.5°C
Predictors Rule Sensitivity Specificity
Fever Fever 92. 0 11. 7
F, C, H, M, A Any of F, C, H, M, A 100. 0 5. 6
C, H, M, A Any of C, H, M, A 96. 0 25. 6
C, H, M Any of C, H, M 80. 0 55. 8
F, H F or H 100. 0 6. 5
C. Symptomatic P. falciparum parasitaemia ≥1,000parasites/μL
plus T≥ 37.5°C
Predictors Rule Sensitivity Specificity
F Fever 100. 0 19. 3
F, H F or H 100. 0 13. 3
D. Symptomatic P. falciparum parasitaemia ≥4,000 parasites/μL
plus T≥ 37.5°C
Predictors Rule Sensitivity Specificity
F Fever 100. 0 19. 5
F, H F or H 100. 0 13. 3
Abbreviations: F fever, C chills, H headache, M Malaise, A appetite.
Table 5 Sensitivity and specificity of combinations of
symptoms for different clinical malaria definitions in
individuals ≥5 years of age
A. Symptomatic P. falciparum parasitaemia
Predictors Rule Sensitivity Specificity
F Fever 55. 2 54. 4
C, F, M, H, V, ~D Any of F, C, ~D, V, H 100. 0 2. 4
C, F, M, ~D Any of F, C, ~D 98. 5 5. 6
F, ~D Either of F, ~D 98. 5 6. 6
~D ~D 96. 9 12. 5
C, F, M, ~D ≥ 2 of C, F, M, ~D 73. 7 43. 5
F, H F or H 96. 8 11. 5
B. Symptomatic P. falciparum parasitaemia plus T≥ 37.5°C
Predictors Rule Sensitivity Specificity
F Fever 64. 7 54. 5
C, F, M, H, V, ~D Any of C, F, M, H, V, ~D 100. 0 2. 1
C, F, M, ~D Any of C, F, M, ~D 98. 3 4. 9
F, ~D F,~D 98. 3 6. 5
~D ~D 96. 6 12. 2
C, F, M, ~D ≥ 2 of C, F, M, ~D 82. 8 40. 9
F, H F or H 96. 6 7. 6
C. Symptomatic P. falciparum parasitaemia ≥1,000 parasites/μL
plus T≥ 37.5°C
Predictors Rule Sensitivity Specificity
F Fever 69. 6 58. 4
F, H F or H 100. 0 23. 0
D. Symptomatic P. falciparum parasitaemia ≥4,000 parasites/μL plus
T≥ 37.5°C
Predictors Rule Sensitivity Specificity
F Fever 64. 8 54. 2
C, F, M, V, ~D, H Any of C, F, M, V, ~D, H 100. 0 2. 0
C, F, M, V, ~D Any of C, F, M, V, ~D 97. 7 4. 8
~D ~D 95. 5 12. 1
C, F, M, V Any of C, F, M, V 84. 1 34. 8
F, H F or H 100. 0 22. 9
Abbreviations: F fever, C chills, H headache, M Malaise, V vomiting, ~D No diarrhoea.
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had improved specificity, but always at the cost of sensitivity.
A combination of fever or headache achieved a sensitivity of
94% and 97% for individuals <5 years and ≥5 years respect-
ively (Tables 4 and 5), but at the cost of greatly decreased
specificity (6. 5%) in individuals ≥5 years. The addition of
headache increased the number of children <5 years who
would be tested for P. falciparum infection by only two per-
sons (6%), but increased the number of individuals ≥5 years
who would be tested by 1,190 persons (92%).
To assess whether more stringent criteria for a defin-
ition of clinical malaria would result in different findings,
sensitivity and specificity of symptom combinations was
assessed for a number of stricter definitions of clinical
malaria, as noted in Tables 4 and 5. Similar patterns were
seen for all alternate definitions of clinical malaria. Finally,
measured fever was incorporated in the clinic into the
“symptom” predictor variable. For the primary definition
of clinical malaria (symptomatic P. falciparum parasit-
aemia), having a history of fever or measured fever in theclinic had a sensitivity and specificity of 94% and 11%, re-
spectively, for children <5 years, and 78% and 44%, re-
spectively, for persons ≥5 years.
Prevalence of asymptomatic parasitaemia
Six hundred and four randomly selected individuals from
the site were assessed for presence of asymptomatic parasit-
aemia in July and November 2007, March, August and
October 2008, February, April, August and October 2009,
and May 2010. Due to movement of individuals during the
study period, different numbers were tested at each time
point, but during the three-year period, only five persons
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with a median parasite density of 240 (interquartile range
[IQR], 200–2,560).
Discussion
Fever is the universal screening tool for clinical malaria
in research studies. This is likely appropriate in chil-
dren <5 years, who constitute the majority of malaria
cases in highly endemic areas, because they are more
likely to develop fever when they have infection than are
older individuals. However in areas such as the highland
area of the present study, a substantial proportion of clin-
ical malaria occurs in individuals ≥5 years [12] and local
clinicians state that fever alone does not detect all cases of
malaria in these individuals. The present study supports
this claim. Almost half of individuals ≥ 5 years who came
to the clinic with symptoms of illness and who had P. fal-
ciparum parasitaemia would not have been captured as
malaria cases had history of fever been the sole screening
criterion. A recent study by D’Acremont et al. found that
in one area of Tanzania, malaria was a less common cause
of fever than other infections, notably respiratory viral in-
fection [13]. The present study answers the inverse ques-
tion (does fever as a symptom capture all cases of clinical
malaria?), and finds that in areas of low malaria transmis-
sion, fever alone may not be an adequate screening criter-
ion for malaria.
A history of fever may be absent in individuals ≥5 years
with parasitaemia for several reasons. Fever may be less evi-
dent in older children and adults than in younger children,
whose temperature may be checked or noted by their par-
ent. This is supported by the only modest increase in sensi-
tivity of a history of fever among individuals ≥5 years who
had a measured fever at the clinic. In areas of higher trans-
mission, parasitaemia could be incidental rather than causa-
tive of symptoms. However in this area, based on the
surveys done, one would expect <0.2% of individuals to
have asymptomatic parasitaemia, so incidental parasitaemia
should account for only a tiny fraction of the parasitaemia
in symptomatic individuals seen in the clinic. In addition,
history of fever had sensitivity only 65% even for clinical
malaria defined as parasitaemia > 4,000 parasites/μL and a
measured fever at the clinic, individuals who in this context
indisputably have clinical malaria. The Nandi words for
each symptom, including fever, were carefully reviewed
with our study field assistants, and verified by the clinical
officers and the local advisory group, and the symptom of
fever was highly sensitive for detection of parasitaemia in
young children, so confusion about the term is unlikely.
The most likely explanation seems to be that other symp-
toms precede fever in older individuals. These symptoms
bring them to the dispensary, at which time some have
measured fever but others remain afebrile. Given the clin-
ical course of malaria, all of these individuals were likely tohave a fever eventually, but in a dispensary setting, particu-
larly in an area of low transmission that is working toward
elimination, one wants to detect malaria early and accur-
ately. Individuals with malaria who have symptoms other
than fever, but are not tested or treated because fever is the
sole screening criterion, are likely to go outside the health
system, and potentially receive inappropriate treatment.
Unfortunately, no symptom combination emerged that
would allow us to detect >90% cases of parasitaemia in in-
dividuals ≥5 years without screening many more unin-
fected individuals. A previous study in highland Uganda
found that a history of fever or presence of measured fever
at the clinic had a sensitivity of 95.7% and a specificity of
25.5% [14], but the findings were not separated by age. In
the present study, reported or measured fever had a sensi-
tivity and specificity of only 78% and 44%, respectively, for
individuals ≥5 years, so reported or measured fever alone
would not be adequate for screening in older individuals.
The simplest combination of symptoms that achieved ap-
proximately 95% sensitivity in individuals ≥ 5 years was
fever or headache (sensitivity 96.8%), but screening with
these two symptoms increased the number of individuals ≥
5 years to be screened to almost twice what was required
with fever (from 1,290 to 2,480). Headache has been noted
in the travel medicine literature to be a frequent complaint
in adult travellers with malaria, though most travellers
with malaria also have fever [15]. The presence of fever
early in travellers, but not in this highland population,
may be due to partial immunity from prior exposure in
this population, resulting parasitaemia that does not pro-
duce immediate fever but does produce other lower-grade
symptoms such as headache.
Definitions that relied on more symptoms were more
complex, but did not have better sensitivity than asking
about fever or headache, so in the present study site, fever
or headache will be used as screening symptoms because
they are the best single set of screening symptoms that will
capture ≥95% individuals with clinical malaria. An alterna-
tive would be to wait for individuals to come in for a re-
peat visit, since malaria likely will eventually result in fever
in all individuals, but this would lead to missed chances to
diagnose malaria, to prolonged parasitaemia in symptom-
atic individuals, and potentially to lost confidence in the
health dispensary. The findings of the present study may
have applicability to other sites of unstable transmission,
and in these areas analysis of symptoms should be done to
determine if screening for fever alone can detect >95% of
individuals who have clinical malaria.
An interesting incidental finding is that the absence of
diarrhoea had 96% sensitivity for detection of clinical mal-
aria in individuals ≥5 years. The finding probably reflects a
combination of the low incidence of clinical malaria at this
site, the frequency of diarrhoea as an illness, the multiple
other causes of diarrhoea in this area, and the relatively
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study findings contrast with those of Coldren et al., who
found a modest association between P. falciparum parasit-
aemia and a history of diarrhoea in adults from three areas
of Kenya with differing malaria transmission intensity [16].
The differences may in part reflect different populations:
the present study was restricted to an area of very low en-
demicity and included children as well as adults.
Conclusions
The present study documents that in a highland area of
unstable transmission, where asymptomatic parasitaemia
is rare, the symptom of fever alone is adequate for detec-
tion of clinical malaria in individuals <5 years but not in
individuals ≥5 years. In areas of high malaria transmission,
malaria occurs most often in children and is deadliest in
children [17-21], so a history of fever, which detects al-
most all cases of malaria in young children, is a reasonable
screening criterion. However, as more areas become areas
of low transmission, disease in adults and adolescents may
form a larger part of the clinical burden, and additional
symptoms may be needed to identify all potential cases.
Individuals in areas of unstable, low transmission differ
from individuals in areas of high transmission, who have
strong clinical immunity, and travellers from non-malaria
endemic areas, who have little or no immunity. The inter-
mediate initial presentation of low-grade symptoms, such
as headache, may reflect their partial clinical immunity.
Studies in other areas of unstable transmission should be
conducted to confirm the results of the present study.Additional files
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